- Article published at:
- Article author: Shahram Lavasani
- Article tag: Histamine
- Article comments count: 0
Drawer menu
The 2025 Nobel Prize in Physiology or Medicine was awarded to Shimon Sakaguchi, Mary Brunkow, and Fred Ramsdell for their groundbreaking discoveries about how the immune system maintains balance and avoids attacking the body’s own tissues.
Their work revealed the essential role of regulatory T cells (Tregs), the immune system’s natural regulators that help maintain a healthy level of immune activation. These discoveries have transformed our understanding of how the immune system stays stable and what happens when this balance is disrupted.
What is becoming increasingly clear is that the gut plays a central role in this immune regulation.
The gut is the body’s largest interface with the external world. Every day, it encounters countless bacteria, nutrients, proteins, and environmental molecules. To manage all of this, the immune system must be strong yet well-regulated - active enough to protect us, but not so reactive that it causes unnecessary inflammation.
Here, the microbiome - the community of beneficial bacteria in the gut - plays an essential role. These bacteria communicate with the immune system through biochemical signals, including short-chain fatty acids (SCFAs) such as butyrate, which are produced when the microbiome breaks down dietary fibers.
SCFAs help support the activity of regulatory immune pathways, including Tregs, which contribute to normal immune balance and help keep inflammatory responses in check.
When the gut microbiome is in balance, the immune system is better supported.
Regulatory T cells are key contributors to maintaining normal immune function. They help:
Because of their central role in immune regulation, Tregs have become a major focus of modern immunology and microbiome research.
For almost two decades, I have been dedicated to understanding how different signals, including those from beneficial gut bacteria, can influence regulatory immune pathways.
At Lund University, I had the privilege to:
Over time, our research showed that only specific bacterial strains, not probiotics in general, have the capacity to influence regulatory immune pathways, including Treg-associated activity.
This insight became foundational for the development of precision probiotics.
We discovered that carefully selected Lactobacillus strains could:
These findings provided early scientific evidence that the microbiome may play a role in supporting the gut-brain axis, an area of growing interest in modern research.
These insights contributed to the development of GutMagnific®, a five-strain precision probiotic formulation designed to:
GutMagnific® has been evaluated in scientific studies and observational settings involving individuals experiencing long-standing gut-related discomfort, immune challenges, and stress-related symptoms connected to the gut-brain axis.
Many users and healthcare professionals report interest in using GutMagnific® as part of a broader strategy to support gut health, immune balance, and well-being, alongside other lifestyle and health measures.
GutMagnific® is a food supplement and is not intended to diagnose, treat, cure, or prevent any disease, but it may support the gut environment that contributes to normal immune function.
The 2025 Nobel Prize highlights how central immune tolerance, mucosal immunity, regulatory T cells, and gut-immune interactions are to overall well-being.
It reinforces what modern science is increasingly showing:
Scientific References
Atarashi, K. et al. (2011). Induction of colonic regulatory T cells by indigenous Clostridium species. Science, 331(6015), 337-341.
Furusawa, Y. et al. (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 504(7480), 446-450.
Teng, F. et al. (2016). Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer’s patch T follicular helper cells. Immunity, 44(4), 875-888.